Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
59
Number of overlapping holdings
96.7%
% of BBP's 65 holdings also in IBBQ
27.1%
% of IBBQ's 218 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 8.5% | 2.1% |
|
AMGEN INC | 2.0% | 8.3% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 9.4% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 3.5% | 1.6% |
|
BIOGEN IDEC INC | 1.6% | 2.0% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to IBBQ
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
SAGE THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 2.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | 1.8% |
|
DYNAVAX TECHNOLOGIES CORP | 1.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 1.6% |
 |
THERAVANCE BIOPHARMA INC | 1.5% |
|
AXSOME THERAPEUTICS, INC. | 1.5% |
|
ARDELYX INC | 1.5% |
BBP Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -7.7% |
|
AMGEN INC | -6.4% |
|
GILEAD SCIENCES INC | -6.3% |
|
REGENERON PHARMACEUTICALS | -5.4% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.5% |
 |
ARGENX SE ADR | -2.2% |
|
SUMMIT THERAPEUTICS INC | -2.1% |
|
ALNYLAM PHARMACEUTICALS INC | -1.9% |
 |
SANOFI-AVENTIS-ADR | -1.7% |
|
ROYALTY PHARMA PLC CLASS A | -1.6% |